Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Syneos Health Inc (NQ: SYNH )

34.07 +0.66 (+1.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Syneos Health Inc

Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
Newly Established Network Will Enable High Quality DCTs & Digital Health Technology Solutions 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
Combined Capabilities Will Help Improve Trial Lifecycles for Patients, Sites & Sponsors 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
Relationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial Solutions 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023
Despite Uncertainties, Survey Hints that Dealmaking Intensity Could Be Poised for a Rebound After a Year of Inertia 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Announces Chief Financial Officer Transition
Reaffirms Full-Year 2022 Revenue Guidance 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Extends Partnership with Medable
Continued Collaboration Will Accelerate Bringing Clinical Trials Closer to the Patient 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Releases 2023 Health Trends
Predicts AI and Machine Learning, Diversity and Medical Affairs will Transform Biopharma Product Development 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Reports Third Quarter 2022 Results
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
Brings Together the Industry’s Most Comprehensive Suite of Modular Patient Services, Optimizing Patient Experience from Prescription to Adherence 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Schedules Third Quarter 2022 Earnings Call for Friday, November 4, 2022
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Appoints William E. Klitgaard Independent Director
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Wins Triangle Business Journal 2022 Leaders in Diversity Award
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Expands Partnership with Datavant to Accelerate Delivery of New Therapies to Patients
Collaboration Streamlines Clinical Trial Tokenization, Further Empowers Medical Affairs, Market Access, HEOR and Commercial Analytics for Clients 
From Syneos Health, Inc.
Via Globe NewsWire
Syneos Health Releases Annual Sustainability Report
Report Spotlights Significant Progress Toward Achieving Company’s Environmental, Social and Governance Goals, Including Climate Pledge and DE&I Objectives 
From Syneos Health, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.